Anika Therapeutics, Inc. 4
4 · Anika Therapeutics, Inc. · Filed Feb 26, 2016
Insider Transaction Report
Form 4
SHERWOOD CHARLES H
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2016-02-24+18,900→ 18,900 totalExercise: $39.69Exp: 2025-02-03→ Common Stock (18,900 underlying)
Footnotes (3)
- [F1]The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, February 3, 2015, the date the Compensation Committee of the Company granted these performance-based stock option awards (the "Performance Grant"). Please also see notes 2 and 3.
- [F2]On February 24, 2016, the Compensation Committee determined and certified that 112.5% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3.
- [F3]The stock options vest in four equal installments on the following dates: February 24, 2016, January 1, 2017, January 1, 2018 and January 1, 2019.